Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma
Clinical trial NCT00396045 · COMPLETED
Trial details
- NCT number
- NCT00396045
- Sponsor
- University of Turin, Italy
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.